Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy

Barth T.; Zeman F.; Helbig H.; Gamulescu M. -A.

首页> 外文期刊>International ophthalmology >Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy

【24h】

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy

机译：玻璃体内抗VEGF治疗次脉络膜中的脉络膜新血管形成肾癌内脉络膜病

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To assess the outcome of patients with choroidal neovascularization (CNV) secondary to punctate inner choroidopathy (PIC) receiving intravitreal anti-VEGF (vascular endothelial growth factor) injections.

机译：评估仲脉络膜内腔体（CNV）的患者的结果，其接受玻璃体内抗VEGF（血管内皮生长因子）注射的点状脉络膜病（PIC）。

著录项

来源
《International ophthalmology》 |2018年第3期|共9页
作者
Barth T.; Zeman F.; Helbig H.; Gamulescu M. -A.;
展开▼
作者单位

Univ Med Ctr Regensburg Dept Ophthalmol Franz Josef Strauss Allee 11 D-93053 Regensburg Germany;

Univ Med Ctr Regensburg Ctr Clin Studies ZKS Franz Josef Strauss Allee 11 D-93053 Regensburg;

Univ Med Ctr Regensburg Dept Ophthalmol Franz Josef Strauss Allee 11 D-93053 Regensburg Germany;

Univ Med Ctr Regensburg Dept Ophthalmol Franz Josef Strauss Allee 11 D-93053 Regensburg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词
Choroidal neovascularization; Punctate inner choroidopathy; Intravitreal antiangiogenic therapy; Anti-VEGF (vascular endothelial growth factor);

机译：脉络膜新生血管;点状内脉络膜病;玻璃体内抗血管生成治疗;抗VEGF（血管内皮生长因子）;
入库时间 2022-08-20 02:22:35

相似文献

外文文献
中文文献
专利

1. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy [J] . Barth T., Zeman F., Helbig H., International ophthalmology . 2018,第3期

机译：玻璃体内抗VEGF治疗次脉络膜中的脉络膜新血管形成肾癌内脉络膜病
2. Intravitreal antiangiogenic treatment for choroidal neovascularization secondary to punctate inner choroidopathy [J] . Barth Teresa, Gamulescu Maria-Andreea, Helbig Horst Investigative ophthalmology & visual science . 2016,第12期

机译：玻璃体内抗血管生成治疗次脉络膜内血管形成，次要脉络膜
3. Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: Results of a 1-year prospective trial [J] . ZhangH., LiuZ.-L., SunP., Retina . 2012,第6期

机译：玻璃体内贝伐单抗作为点状内脉络膜病变继发于脉络膜新生血管的主要治疗方法：一项为期一年的前瞻性研究结果
4. . Subfoveal choroidal neovascularization in punctate inner choroidopathy: surgical management andpathological findings [C] . T.W. OLSEN, A. CAPONE Jr, P. STERNBERG Jr, European Macula Group . 1998

机译：。点状内脉络膜病的子胚肠脉络膜新生血管形成：手术管理和嗜睡结果
5. Clinical Features of Treated and Untreated Type 1 Idiopathic Macular Telangiectasia Without the Occurrence of Secondary Choroidal Neovascularization Followed for 2 Years in Japanese Patients [D] . 逢坂理恵 2019

机译：在日本患者中治疗和未治疗的1型特发性黄斑部毛细血管扩张症的临床特征为继发性脉络膜新血管形成，随访2年
6. Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy [O] . Bettina Hohberger, Michael Rudolph, Antonio Bergua 1909

机译：脉状新生血管形成与点状内脉络膜病变：玻璃体内抗VEGF和全身免疫抑制治疗的组合
7. Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy [O] . Bettina Hohberger, Michael Rudolph, Antonio Bergua 2015

机译：脉络膜新生血管形成与点状内部脉络膜病相结合：玻璃体内抗VEGF和系统性免疫抑制治疗相结合

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to punctate inner choroidopathy

摘要

著录项

相似文献

相关主题

期刊订阅